AlbertSDenittisMDMS FCPP

Radiation Oncology • Wynnewood, PA

Chief Lankenau Medical Center

Join to view full profile

Dr. Denittis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Denittis' full profile

Already have an account?

Office
100 E Lancaster Ave
Wynnewood, PA 19096
Phone+1 484-476-2433
Is this information wrong?

Education & Training

University of Pennsylvania Health SystemResidency, Radiation Oncology, 1998 - 2000
Cooper Hospital-University Medical CenterResidency, Radiation Oncology, 1996 - 1998
Cooper Medical School of Rowan University/Cooper University HospitalInternship, Internal Medicine, 1995 - 1996
Rutgers Robert Wood Johnson Medical SchoolClass of 1995

Certifications & Licensure

NJ State Medical License 1996 - 2025
PA State Medical License 1997 - 2024
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Philadelphia Magazine Castle Connolly, 2012-2014

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
Completed
Phase 2
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
Unknown status
Not Applicable
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
Active, not recruiting
Phase 3
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Start of enrollment: 2012 May 01
Active, not recruiting
Phase 3
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer Start of enrollment: 2012 Jul 01
Completed
Phase 2
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
Completed
Phase 1, Phase 2
Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer Start of enrollment: 2012 Oct 01
Active, not recruiting
Not Applicable
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Start of enrollment: 2012 Nov 01
Completed
Phase 3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy Start of enrollment: 2008 Dec 01
Completed
Not Applicable
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
Active, not recruiting
Phase 2
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of N...
Rahul Khairnar, Lyudmila DeMora, Howard M Sandler, W Robert Lee, Ester Villalonga-Olives, C Daniel Mullins, Francis B Palumbo, Deborah W Bruner, Fadia T Shaya, Soren M...> ;JCO Clinical Cancer Informatics. 2022 Jun 1
1 citations
Association of Pretreatment Hippocampal Volume With Neurocognitive Function in Patients Treated With Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Meta...
Christopher D Abraham, Stephanie L Pugh, Joseph A Bovi, Vinai Gondi, Minesh P Mehta, Tammie Benzinger, Christopher J Owen, Simon S Lo, Vijayananda Kundapur, Paul D Bro...> ;Advances in Radiation Oncology. 2021 Dec 11
A Survey of Breast Cancer Patients' Use of Cannabis During Radiation Therapy.
M. Weiss, S. Danese, K.Aliano Ruiz, S. Kjelstrom, Meghan Buckley, Adam Leitenberger, M. Bollmann-Jenkins, Sharon Larson, Albert S. DeNittis, Diana Martinez> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
Consideration of Margin in SRS/SRT Plans for Brain Metastases Treatment With Volumetric Modulated Radiotherapy
D. Wang, Albert S. DeNittis> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
2 citations
Psychological Treatment for Patients Receiving Radiation: Results of NRG Oncology/RTOG 0841
William Small, Stephanie L. Pugh, Lynne I. Wagner, Jeffrey J. Kirshner, Kulbir Sidhu, Martin J. Bury, Albert S. DeNittis, Tracy E. Alpert, Binh N. Tran, Beatrice F. Bl...> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Feb 7
3 citations
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415.
Rahul Khairnar, Stephanie L. Pugh, Howard M. Sandler, W. Robert Lee, Ester Villalonga Olives, C. Daniel Mullins, Francis B. Palumbo, Deborah Watkins Bruner, Fadia T. S...> ;Plos One. 2021 Apr 14
5 citations
Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer.
Audrey Dang, Rebecca Levin-Epstein, David Shabsovich, Minsong Cao, Christopher R. King, Fang-I Chu, Constantine Mantz, Kevin L. Stephans, Chandana A. Reddy, D. Andrew ...> ;Advances in Radiation Oncology. 2020 May 1
6 citations
Strategies to optimize stereotactic radiosurgery plans for brain tumors with volumetric-modulated arc therapy
David Wang, Albert S. DeNittis, Yibing Hu> ;Journal of Applied Clinical Medical Physics. 2020 Feb 11
Optimal prescription isodose line in SBRT for lung tumor treatment with volumetric-modulated arc therapy.
David Wang, Albert S. DeNittis, Tracey L. Evans, Thomas Meyer> ;Journal of Radiosurgery and SBRT. 2020 Jan 1
14 citations
Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases...
Joseph Bovi, Stephanie L. Pugh, David S. Sabsevitz, Clifford G. Robinson, Eric S. Paulson, Minesh P. Mehta, Vinai Gondi, Vijayananda Kundapur, Mark S. Shahin, Samuel T...> ;Advances in Radiation Oncology. 2019 Oct 1
12 citations
Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncol...
Amina Ahmed, Wei Deng, William P. Tew, David Bender, Robert S. Mannel, Ramey D. Littell, Albert S. DeNittis, Mitchell I. Edelson, Mark A. Morgan, Jay W. Carlson, Chris...> ;Gynecologic Oncology. 2018 Aug 1
42 citations
Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer
John H Marks, Elizabeth A. Myers, Erik L. Zeger, Albert S. DeNittis, Mounica Gummadi, Gerald J. Marks> ;Surgical Endoscopy. 2017 Jun 22
4 citations
Photon irradiation using a water bath technique for treatment of confluent carcinoma in situ of the hand, digits, and nail bed: a case report.
Chelain R. Goodman, Albert S. DeNittis> ;Journal of Medical Case Reports. 2017 Mar 30
24 citations
A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of...
Shannon Fogh, Snehal Deshmukh, Lawrence Berk, Amylou C. Dueck, Kevin S. Roof, Sherif Yacoub, Thomas Gergel, Kevin L. Stephans, Andreas Rimner, Albert S. DeNittis, John...> ;International Journal of Radiation Oncology, Biology, Physics. 2017 Mar 15
70 citations
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTC...
Ethan Basch, Stephanie L. Pugh, Amylou C. Dueck, Sandra A. Mitchell, Lawrence Berk, Shannon Fogh, Lauren J. Rogak, Marcha L. Gatewood, Bryce B. Reeve, Tito R. Mendoza,...> ;International Journal of Radiation Oncology, Biology, Physics. 2017 Jun 1
20 citations
Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial.
Lynne I. Wagner, Stephanie L. Pugh, William Small, Jeffrey J. Kirshner, Kulbir Sidhu, Martin J. Bury, Albert S. DeNittis, Tracy E. Alpert, Binh N. Tran, Beatrice F. Bl...> ;Cancer. 2017 Feb 1
64 citations
Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235.
Nitin Ohri, Fenghai Duan, Bradley S. Snyder, Bo Wei, Mitchell Machtay, Abass Alavi, Barry A. Siegel, Douglas W. Johnson, Jeffrey D. Bradley, Albert S. DeNittis, Maria ...> ;Journal of Nuclear Medicine. 2016 Jun 1
28 citations
CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.
Chip Caine, Snehal Deshmukh, Vinai Gondi, Minesh P. Mehta, Wolfgang A. Tomé, Benjamin W. Corn, Andrew A. Kanner, Howard Rowley, Vijayananda Kundapur, Albert S. DeNitti...> ;Journal of Neuro-Oncology. 2016 Jan 1
59 citations
NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination W...
Theodore S. Hong, Jennifer Moughan, Michael C. Garofalo, Johanna C. Bendell, Adam C. Berger, Nicklas B.E. Oldenburg, Pramila R. Anne, Francisco Perera, R. Jeffrey Lee,...> ;International Journal of Radiation Oncology, Biology, Physics. 2015 Sep 1
52 citations
Pretreatment FDG-PET Metrics in Stage III Non–Small Cell Lung Cancer: ACRIN 6668/RTOG 0235
Nitin Ohri, Fenghai Duan, Mitchell Machtay, Jeremy Gorelick, Bradley S. Snyder, Abass Alavi, Barry A. Siegel, Douglas W. Johnson, Jeffrey D. Bradley, Albert S. DeNitti...> ;Journal of the National Cancer Institute. 2015 Apr 1
704 citations
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Pha...
Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé, Chip Caine, Ben W Corn, Andrew A. Kanner, Howard A. Rowley, Vijayananda Kundapur, Albert S. DeNittis, Jeffrey Greensp...> ;Journal of Clinical Oncology. 2014 Dec 1
133 citations
Prediction of Survival by [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer Undergoing Definitive Chemo...
Mitchell Machtay, Fenghai Duan, Barry A. Siegel, Bradley S. Snyder, Jeremy Gorelick, Janet S. Reddin, Reginald F. Munden, Douglas W. Johnson, Larry H. Wilf, Albert S. ...> ;Journal of Clinical Oncology. 2013 Oct 20
47 citations
CONCURRENT WHOLE BRAIN RADIOTHERAPY AND SHORT-COURSE CHLOROQUINE IN PATIENTS WITH BRAIN METASTASES: A PILOT TRIAL.
Harriet Belding Eldredge, Albert S. DeNittis, James B. DuHadaway, Michael R. Chernick, Richard P. Metz, George C. Prendergast> ;Journal of Radiation Oncology. 2013 Sep 1
4 citations
A bioactive probe of the oxidative pentose phosphate cycle: novel strategy to reverse radioresistance in glucose deprived human colon cancer cells.
Jie Li, Kathleen M. Ward, Donglan Zhang, Eswarkumar Dayanandam, Albert S. DeNittis, George C. Prendergast, Iraimoudi S. Ayene> ;Toxicology in Vitro. 2013 Feb 1
7 citations
Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma
Xinglei Shen, Albert S. DeNittis, Maria Werner-Wasik, Rita Axelrod, Paul B. Gilman, Thomas J. Meyer, Joseph Treat, Walter J. Curran, Mitchell Machtay> ;Radiation Oncology. 2011 Feb 16
Join now to see all

Press Mentions

Advanced Medical Isotope’s CEO Releases Shareholder Letter Outlining New Streamlined Path to FDA SubmissionFebruary 14th, 2017
Sanofi Appoints Dr. Yong-Jun Liu as Head of Research (Sanofi SA)March 29th, 2016
Former Patient Drops off 'Comfort Kits' to Cancer Patients at Northwestern Medicine Lake Forest Hospital (Northwestern Memorial HealthCare)March 28th, 2016
Join now to see all